These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. SARS-CoV-2 binding and neutralizing antibody levels after Ad26.COV2.S vaccination predict durable protection in rhesus macaques. Roozendaal R; Solforosi L; Stieh DJ; Serroyen J; Straetemans R; Dari A; Boulton M; Wegmann F; Rosendahl Huber SK; van der Lubbe JEM; Hendriks J; Le Gars M; Dekking L; Czapska-Casey DN; Guimera N; Janssen S; Tete S; Chandrashekar A; Mercado NB; Yu J; Koudstaal W; Perez-Ruixo JJ; Sadoff J; Barouch DH; Schuitemaker H; Zahn R Nat Commun; 2021 Oct; 12(1):5877. PubMed ID: 34620860 [TBL] [Abstract][Full Text] [Related]
30. Immunogenicity and Reactogenicity of Ad26.COV2.S in Korean Adults: A Prospective Cohort Study. Hyun H; Choi MJ; Heo JY; Seo YB; Nham E; Yoon JG; Seong H; Noh JY; Cheong HJ; Kim WJ; Choi JY; Lee YJ; Lee HW; Kim SS; Kim B; Song JY J Korean Med Sci; 2022 Jul; 37(27):e210. PubMed ID: 35818701 [TBL] [Abstract][Full Text] [Related]
31. Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study. Costa Clemens SA; Weckx L; Clemens R; Almeida Mendes AV; Ramos Souza A; Silveira MBV; da Guarda SNF; de Nobrega MM; de Moraes Pinto MI; Gonzalez IGS; Salvador N; Franco MM; de Avila Mendonça RN; Queiroz Oliveira IS; de Freitas Souza BS; Fraga M; Aley P; Bibi S; Cantrell L; Dejnirattisai W; Liu X; Mongkolsapaya J; Supasa P; Screaton GR; Lambe T; Voysey M; Pollard AJ; Lancet; 2022 Feb; 399(10324):521-529. PubMed ID: 35074136 [TBL] [Abstract][Full Text] [Related]
32. Durable Humoral and Cellular Immune Responses Following Ad26.COV2.S Vaccination for COVID-19. Barouch DH; Stephenson KE; Sadoff J; Yu J; Chang A; Gebre M; McMahan K; Liu J; Chandrashekar A; Patel S; Le Gars M; de Groot AM; Heerwegh D; Struyf F; Douoguih M; van Hoof J; Schuitemaker H medRxiv; 2021 Jul; ():. PubMed ID: 34268527 [TBL] [Abstract][Full Text] [Related]
33. Predictors of long-term neutralizing antibody titers following COVID-19 vaccination by three vaccine types: the BOOST study. Prather AA; Dutcher EG; Robinson J; Lin J; Blackburn E; Hecht FM; Mason AE; Fromer E; Merino B; Frazier R; O'Bryan J; Drury S; Epel ES Sci Rep; 2023 May; 13(1):6505. PubMed ID: 37160978 [TBL] [Abstract][Full Text] [Related]
34. Comparison of BNT162b2-, mRNA-1273- and Ad26.COV2.S-Elicited IgG and Neutralizing Titers against SARS-CoV-2 and Its Variants. Padhiar NH; Liu JB; Wang X; Wang XL; Bodnar BH; Khan S; Wang P; Khan AI; Luo JJ; Hu WH; Ho WZ Vaccines (Basel); 2022 May; 10(6):. PubMed ID: 35746466 [TBL] [Abstract][Full Text] [Related]
36. Quantifying Antibody Persistence After a Single Dose of COVID-19 Vaccine Ad26.COV2.S in Humans Using a Mechanistic Modeling and Simulation Approach. Dari A; Boulton M; Neyens M; Le Gars M; Valenzuela B; Shukarev G; Cárdenas V; Ruiz-Guiñazú J; Sadoff J; Hoetelmans RMW; Ruixo JJP Clin Pharmacol Ther; 2023 Feb; 113(2):380-389. PubMed ID: 36377532 [TBL] [Abstract][Full Text] [Related]
37. Comparative Effectiveness of mRNA-based BNT162b2 Vaccine versus Adenovirus Vector-Based Ad26.COV2.S Vaccine for the Prevention of COVID-19 among Dialysis Patients. Brunelli SM; Sibbel S; Karpinski S; Marlowe G; Walker AG; Giullian J; Van Wyck D; Kelley T; Lazar R; Zywno ML; Connaire JJ; Young A; Tentori F J Am Soc Nephrol; 2022 Apr; 33(4):688-697. PubMed ID: 35135894 [TBL] [Abstract][Full Text] [Related]
38. Immunogenicity and efficacy of one and two doses of Ad26.COV2.S COVID vaccine in adult and aged NHP. Solforosi L; Kuipers H; Jongeneelen M; Rosendahl Huber SK; van der Lubbe JEM; Dekking L; Czapska-Casey DN; Izquierdo Gil A; Baert MRM; Drijver J; Vaneman J; van Huizen E; Choi Y; Vreugdenhil J; Kroos S; de Wilde AH; Kourkouta E; Custers J; van der Vlugt R; Veldman D; Huizingh J; Kaszas K; Dalebout TJ; Myeni SK; Kikkert M; Snijder EJ; Barouch DH; Böszörményi KP; Stammes MA; Kondova I; Verschoor EJ; Verstrepen BE; Koopman G; Mooij P; Bogers WMJM; van Heerden M; Muchene L; Tolboom JTBM; Roozendaal R; Brandenburg B; Schuitemaker H; Wegmann F; Zahn RC J Exp Med; 2021 Jul; 218(7):. PubMed ID: 33909009 [TBL] [Abstract][Full Text] [Related]